Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Viz.ai, Inc.

Viz.ai Receives First and Only FDA 510(k) Clearance for Subdural Measurements
From Viz.ai, Inc.
Via Business Wire
New Study Demonstrates AI-Powered Care Coordination Reduces Transfer Time and Improves Outcomes in Intracerebral Hemorrhage Patients
From Viz.ai, Inc.
Via Business Wire
Viz.ai Launches Viz 3D CTA™ to Deliver Enhanced Imaging and Accelerate Clinical Decision-Making
From Viz.ai, Inc.
Via Business Wire
New Study Demonstrates Significant Impact of AI-Powered Communication in Stroke Patients with Cardiac Shunts
From Viz.ai, Inc.
Via Business Wire
Viz.ai and Illuminate Expand Partnership to Improve Cerebral Aneurysm Patient Care
From Viz.ai, Inc.
Via Business Wire
Viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patients
From Viz.ai, Inc.
Via Business Wire
Viz.ai Announces New Clinical Data Demonstrating Fewer Futile Transfers and Substantial Cost Savings in Stroke
From Viz.ai, Inc.
Via Business Wire
TIME Selects Viz.ai CEO Dr. Chris Mansi in TIME100 AI List of the World's Most Influential People in Artificial Intelligence
From Viz.ai, Inc.
Via Business Wire
Viz.ai Collaborates with Hypertrophic Cardiomyopathy Association to Improve Care for Hypertrophic Cardiomyopathy Patients
From Viz.ai, Inc.
Via Business Wire
Viz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States
From Viz.ai, Inc.
Via Business Wire
Viz.ai Announces Expansion Into Outpatient Ambulatory Centers to Accelerate Clinical Trial Recruitment in Heart Failure
From Viz.ai, Inc.
Via Business Wire
New Clinical Data Supports Viz.ai Solution for Improved Pulmonary Embolism Detection and Care Coordination
From Viz.ai, Inc.
Via Business Wire
Viz.ai to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
From Viz.ai, Inc.
Via Business Wire
Viz.ai Wins Comparably Awards for Best Place to Work for Second Year
From Viz.ai, Inc.
Via Business Wire
Viz.ai Named to Forbes AI 50 List of Top Artificial Intelligence Companies of 2023
From Viz.ai, Inc.
Via Business Wire
Viz.ai Launches Viz™ Trauma Suite to Support Change in Trauma Center Standards
From Viz.ai, Inc.
Via Business Wire
CORRECTING and REPLACING Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal Aortic Aneurysm
From Viz.ai, Inc.
Via Business Wire
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial
From Viz.ai, Inc.
Via Business Wire
Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management of Suspected Hypertrophic Cardiomyopathy (HCM)
From Viz.ai, Inc.
Via Business Wire
Viz.ai Collaborates with Johns Hopkins to Expedite Patient Enrollment in Brain Injury Trial
From Viz.ai, Inc.
Via Business Wire
Large Real-World, Multi-Center Study Demonstrates Viz.ai Platform Saves Critical Minutes in Stroke Care
From Viz.ai, Inc.
Via Business Wire
Viz.ai and Cercare Medical Partner to Support Neurovascular Clinical Decision Making
From Viz.ai, Inc.
Via Business Wire
Viz.ai Appoints Radiology Advisory Board to Advance Innovation
From Viz.ai, Inc.
Via Business Wire
Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment
From Viz.ai, Inc.
Via Business Wire
Viz.ai partners with Illuminate to improve quality of care for aortic aneurysm patients
From Viz.ai, Inc.
Via Business Wire
New Study Finds 85% of Aneurysms Identified by Viz™ ANEURYSM had not Been Referred for Neurovascular Review
From Viz.ai, Inc.
Via Business Wire
Viz.ai Launches AI-Powered VizTM Cardio Suite
From Viz.ai, Inc.
Via Business Wire
Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™ Platform
From Viz.ai, Inc.
Via Business Wire
Viz.ai Names Jieun Choe Chief Marketing Officer
From Viz.ai, Inc.
Via Business Wire
Viz.ai Receives FDA 510(k) Clearance for Automated RV/LV Analysis Algorithm
From Viz.ai, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.